Insights

Acquisition Legacy Leverage AbbVie’s past acquisition to position Stemcentrx’s oncology platforms as a legacy asset with proven exit value, highlighting potential for partnership or licensing opportunities around cancer stem cell targeting and antibody-drug conjugates.

Clinical Progress Alignment Align discussions around the company’s rapid translation from target discovery to clinical trials, appealing to partners seeking accelerated development timelines and GMP manufacturing capabilities to de-risk collaboration on early to mid-stage oncology programs.

Targeted Platforms Market the proprietary cancer stem cell platforms and ADC engineering capabilities as differentiators for solid tumor programs, presenting co-development or revenue-sharing models with large pharma seeking novel targets and differentiated therapies.

Geographic Footprint Emphasize South San Francisco lab and manufacturing capabilities to attract regional or global partners requiring integrated R&D and GMP production, offering can-do access to end-to-end development pipelines.

Strategic Fit PositionStemcentrx as a potential bolt-on for pharma companies with oncology portfolios looking to expand into cancer stem cell biology, proposing collaboration frameworks for target discovery, antibody engineering, and ADC development to complement existing assets.

Stemcentrx, Inc. Tech Stack

Stemcentrx, Inc. uses 1 technology products and services including Apache, and more. Explore Stemcentrx, Inc.'s tech stack below.

  • Apache
    Web Servers

Stemcentrx, Inc.'s Email Address Formats

Stemcentrx, Inc. uses at least 1 format(s):
Stemcentrx, Inc. Email FormatsExamplePercentage
First.Last@stemcentrx.comJohn.Doe@stemcentrx.com
99%
F.Last@stemcentrx.comJ.Doe@stemcentrx.com
1%

Frequently Asked Questions

What is Stemcentrx, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Stemcentrx, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Stemcentrx, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s official website is stemcentrx.com and has social profiles on LinkedInCrunchbase.

What is Stemcentrx, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Stemcentrx, Inc. have currently?

Minus sign iconPlus sign icon
As of July 2026, Stemcentrx, Inc. has approximately 6 employees across 2 continents, including North AmericaEurope. Key team members include Manager Statistics: S. E.Project Manager: V. D.Associate Scientist Ii: A. T.. Explore Stemcentrx, Inc.'s employee directory with LeadIQ.

What industry does Stemcentrx, Inc. belong to?

Minus sign iconPlus sign icon
Stemcentrx, Inc. operates in the Biotechnology Research industry.

What technology does Stemcentrx, Inc. use?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s tech stack includes Apache.

What is Stemcentrx, Inc.'s email format?

Minus sign iconPlus sign icon
Stemcentrx, Inc.'s email format typically follows the pattern of First.Last@stemcentrx.com. Find more Stemcentrx, Inc. email formats with LeadIQ.

How much funding has Stemcentrx, Inc. raised to date?

Minus sign iconPlus sign icon
As of July 2026, Stemcentrx, Inc. has raised $516M in funding. The last funding round occurred on Sep 09, 2015 for $250M.

When was Stemcentrx, Inc. founded?

Minus sign iconPlus sign icon
Stemcentrx, Inc. was founded in 2008.
Stemcentrx, Inc. logo

Stemcentrx, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Stemcentrx, Inc. is a biotechnology research company located in South San Francisco, California. Founded in 2008, it integrates laboratory discovery with GMP manufacturing to accelerate moving from target discovery to clinical testing. The company's work centers on cancers by identifying cancer stem cells, uncovering novel targets, and designing and producing antibodies and antibody-drug conjugates. This approach spans early research through clinical investigation, with laboratories and manufacturing facilities described as state-of-the-art. The culture is portrayed as focused and collaborative, echoing the startup environment of the region.

Its stated mission is to develop therapies that cure or substantially improve survival for cancer patients, reflecting a focus on strategies aimed at eradicating cancer stem cells that initiate and sustain tumors. In the biotechnology sector, Stemcentrx positions itself at the intersection of discovery and therapeutic development, aiming to translate scientific insight into patient-accessible treatments. The firm appears to target serious, potentially lethal cancers through its proprietary platforms and manufacturing capabilities. The company employs a small team, reflecting its status as a compact organization within the broader life sciences ecosystem of South San Francisco.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
2-10

Section iconFunding & Financials

  • $516M

    Stemcentrx, Inc. has raised a total of $516M of funding over 4 rounds. Their latest funding round was raised on Sep 09, 2015 in the amount of $250Mas a series_g.

  • $10M$25M

    Stemcentrx, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $516M

    Stemcentrx, Inc. has raised a total of $516M of funding over 4 rounds. Their latest funding round was raised on Sep 09, 2015 in the amount of $250Mas a series_g.

  • $10M$25M

    Stemcentrx, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.